Less Ads, More Data, More Tools Register for FREE

Pin to quick picksTekCapital Regulatory News (TEK)

Share Price Information for TekCapital (TEK)

Share Price is delayed by 15 minutes
Get Live Data
5.80    -0.10 (-1.69%)
Bid:
5.70
Ask:
5.90
Spread: 0.20 (3.509%)
Market Cap: £14.92m
TEK Live PriceLast checked at - London Stock Exchange

Intraday TekCapital Share Chart

Placing

6 May 2015 07:01

RNS Number : 2757M
Tekcapital plc
06 May 2015
 

 

6 May 2015

 

Tekcapital plc

("Tekcapital" or "the "Company")

 

Placing to raise £2.15 million

 

The Board of Tekcapital (AIM: TEK), an international provider of technology and intellectual property services, is pleased to announce that the Company has raised gross proceeds of £2.15 million, by way of a placing (the "Placing") of a total of 10,750,000 new ordinary shares of 0.4p each (the "Placing Shares") at a price of 20 pence per share (the "Placing Price"). The Placing, which was conducted by Allenby Capital Limited and Optiva Securities Limited, was oversubscribed.

 

Summary:

 

· Gross proceeds of the Placing amount to a total of £2.15 million, estimated to be £2.02 million net of expenses, excluding VAT.

 

· The net proceeds of the Placing will be used for two purposes:

 

o To expand Tekcapital's sales force to accelerate the growth of its client base for technology transfer and InventionEvaluator services; and

o To enable Tekcapital to acquire and sell-on the licences for additional university intellectual properties.

 

· The Placing Shares will be issued to a range of institutional and other investors, including existing and new shareholders in the Company.

 

· Continuing pipeline of intellectual property licence opportunities for potential acquisition.

 

 

Commenting on the Placing, Dr. Clifford M. Gross, the Company's Chairman, said: "I am very encouraged by the significant level of support that we have received from existing shareholders and also from new investors who have chosen to participate in our growth story. The funds raised will enable us to accelerate our strategy with an expanded sales force driving new client acquisition. We are also continuing to see several extremely interesting technologies in the market place that we believe are suitable for out-licence and have the potential to realise significant value for our shareholders."

 

 

Background to and reasons for the Placing

 

On 14 April 2015, Tekcapital announced that it had acquired the exclusive worldwide licence to a portfolio of 13 optical technology patents from the University of Central Florida. This was the fourth technology licence acquisition transaction that the Company has completed since January 2015 and adds to the previous technology licence acquisitions in the areas of reduced-fat food production (a process called Crackle-BakedTM) and non-invasive glucose measurement for diabetics.

 

Since its admission to AIM, Tekcapital has developed its business and significantly expanded its client base, through the hiring of key sales and marketing executives to drive the adoption of its services. The Company has opened new offices in Miami and Singapore and has signed up new clients in Israel, Finland and the United States.

 

The net proceeds of the Placing will allow Tekcapital to expand its sales force to accelerate the growth of its client base for technology transfer. This will include staff additions in sales, plus advertising and marketing support. In addition, the net proceeds of the Placing will be used to acquire multiple university intellectual property rights for follow on out-licensing or sale.

 

The Placing

 

The Company has raised gross proceeds of £2.15 million (approximately £2.02 million net of estimated expenses before VAT) through the issue of the Placing Shares. The Placing Price represents a discount of approximately 8 per cent. to the closing mid-market price on AIM of Tekcapital's shares of 21.75p on 5 May 2015, being the latest practicable date prior to this announcement. The Placing Shares will represent approximately 31 per cent. of the Company`s enlarged ordinary share capital immediately following Admission (as defined below).

 

Application has been made to the London Stock Exchange for the Placing Shares to be admitted to trading on AIM ("Admission"). It is expected that Admission will become effective, and dealings in the Placing Shares will commence, at 8:00 am on 11 May 2015.

 

The Placing Shares will be issued credited as fully paid and will rank in full for all dividends and other distributions declared, made or paid in respect of the Company`s ordinary shares of 0.4p each ("Ordinary Shares") after the date of Admission and will otherwise rank pari passu in all respects with the Company`s existing Ordinary Shares.

 

Total Voting Rights

 

The enlarged issued share capital of the Company following the issue of the Placing Shares will be 34,678,539 Ordinary Shares with voting rights. The Company does not hold any Ordinary Shares in Treasury.

 

Following Admission, the above figure of 34,678,539 Ordinary Shares may be used by shareholders in the Company as the denominator for the calculations by which they will determine if they are required to notify their interest in, or change to their interest in, the share capital of the Company under the Financial Conduct Authority's Disclosure and Transparency Rules.

 

Shareholdings in the Company

 

Following the issue of the Placing Shares, the holdings of the directors of Tekcapital and other shareholders holding in excess of 3 per cent. of the Company's enlarged share capital on Admission are, to the best of the knowledge of the Board of Tekcapital, as follows:

 

Name of Shareholder

Holding of Ordinary Shares

% of enlarged share capital

Clifford M. Gross, Ph.D. (Chairman)

8,657,500

24.97%

Bill Payne (Non-executive Director)

400,000

1.15%

Jeffrey Lewis, J.D. (Non-executive Director)

100,000

0.29%

Carl Nisser, J.D. (Non-executive Director)

100,000

0.29%

Alexander Maxwell Hamilton Inglis

1,525,000

4.40%

RBC Trustees (CI) Limited as trustees of the Priory Accumulation & Maintenance Trust and the Edna Wray Grandchildren's Accumulation & Maintenance Trust (Nigel Wray's family trusts)

6,000,000

17.30%

 

 

 

For further information please contact:

 

Tekcapital plc

+1 305 200 3450 Ext 305

Clifford M. Gross

cgross@tekcapital.com

Allenby Capital Ltd (Nominated Adviser & Joint Broker)

+44 (0) 20 3328 5656

Jeremy Porter / Alex Brearley

Optiva Securities Limited (Joint Broker)

+44 (0) 20 3137 1904

Jeremy King / Vishal Balasingham

jeremy.king@optivasecurities.com

FTI Consulting, LLP

+44 (0) 20 3727 1000

Chris Lane / Emma Appleton / Roger Newby

tekcapital@fticonsulting.com

 

 

Tekcapital plc - The World's Largest University Network for Open Innovation

 

Tekcapital helps clients profit from new, university-developed intellectual properties. With our proprietary discovery search engine, linked to 4,000+ universities in 160 countries, coupled with expert scientific review, we provide a turn-key service to make it easy for clients to find and acquire the IP they need to create a competitive advantage. Tekcapital plc is listed on the AIM market of the London Stock Exchange (AIM: symbol TEK) and is headquartered in Oxford, in the UK. For more information, please visit www.tekcapital.com.

 

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
IOEUVVWRVAAVRAR
Date   Source Headline
4th May 20181:45 pmRNSFinal Results
19th Apr 20187:00 amRNSUK Investor Show
1st Mar 20187:00 amRNSUpdate on Lucyd Blockchain Token Generation Event
14th Feb 20187:00 amRNSPrivate Placement for Belluscura to raise US$1.33m
24th Jan 20187:00 amRNSHolding(s) in Company
22nd Jan 20187:00 amRNSUpdate on Lucyd Blockchain Token Generation Event
18th Dec 20174:14 pmRNSHolding(s) in Company
1st Dec 201710:14 amRNSUpdate re. Belluscura IPO
16th Nov 20178:00 amRNSUpdate re. Belluscura IPO
30th Oct 20177:00 amRNSAcquisition of a Patented AI Valet System
28th Sep 20177:00 amRNSPortfolio Company to Raise Funds via a Token Sale
22nd Sep 20177:00 amRNSInvestor Briefing
31st Jul 20177:00 amRNSHalf-year Report
31st May 201711:18 amRNSResult of AGM
31st May 20177:00 amRNSAcquisition of New Gesture Recognition Technology
9th May 20175:13 pmRNSFinal Results
8th May 20179:11 amRNSNotice of AGM
3rd May 20177:00 amRNSPrivate Placement for Belluscura Ltd
2nd May 20179:31 amRNSApp to Search Global University IP
25th Apr 20177:00 amRNSBelluscura acquires Nanotether Discovery Science
20th Mar 20179:11 amRNSHolding(s) in Company
16th Mar 20179:30 amRNSHolding(s) in Company
10th Mar 20179:31 amRNSExercise of Warrants
3rd Mar 20177:00 amRNSBelluscura Launches Passport Medical Device in US
2nd Mar 20177:00 amRNSBelluscura Ltd Launches Slyde in EU
1st Mar 20177:00 amRNSBelluscura Ltd Launches Wire CaddyT In USA
28th Feb 20177:00 amRNSLicense and Development Agreement
15th Feb 20177:00 amRNSAppointment of Joint Broker
2nd Feb 20179:55 amRNSHolding(s) in Company
1st Feb 20175:25 pmRNSHolding(s) in Company
31st Jan 20174:26 pmRNSTotal Voting Rights and Holding in Company
26th Jan 20173:00 pmRNSResults of proposed placing to raise £2.4m
26th Jan 20177:00 amRNSProposed placing
12th Jan 20177:00 amRNSNotice of Allowance for Energy Harvester Patent
4th Jan 20177:00 amRNSSuccessful Production and Testing of µSaltTM
28th Dec 20167:00 amRNSOut-licence & Strategic Alliance with Wecast
9th Nov 20167:00 amRNSDirectorate Change
31st Oct 20167:00 amRNSStrategic Alliance with Bajainnova SAPI de CV
28th Oct 20167:00 amRNSNotice of Allowance for 2nd Crackle-baked Patent
25th Oct 20167:00 amRNSPrivate Placement for Belluscura Ltd
7th Oct 20164:28 pmRNSHolding(s) in Company
15th Sep 20167:00 amRNSAcquisition of Medical Device Licence
31st Aug 20167:00 amRNSHalf-year Report
30th Jun 20167:30 amRNSGrant of Options
17th Jun 20167:00 amRNSPrivate Placement for Belluscura Ltd
6th Jun 201611:44 amRNSAcquisition of salt reduction technology patent
27th May 20162:47 pmRNSResult of AGM
4th May 20167:00 amRNSPosting of Annual Report and Notice of AGM
29th Apr 20167:00 amRNSFinal Results
28th Apr 20167:00 amRNSAcquisition and Total Voting Rights

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.